Windtree Therapeutics Inc /De/ (WINTW) — 10-Q Filings

10-Q Filings (6)

• Windtree's Q3 Loss Widens on Impairment, Debt Costs — Nov 19, 2025 Risk: high
  WINDTREE THERAPEUTICS INC /DE/ reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $(42,761) thousand, a substant
• Windtree Therapeutics Q2 2025 Update — Aug 19, 2025 Risk: medium
  Windtree Therapeutics Inc. filed a 10-Q for the period ending June 30, 2025. The company reported total assets of $5.5 million and total liabilities of $5.5 mil
• Windtree Therapeutics Files Q1 2025 10-Q — May 15, 2025 Risk: high
  Windtree Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company reported minimal revenue and significant operating expenses, with a
• Windtree Therapeutics Q3 2024: Net Loss Continues — Nov 26, 2024 Risk: high
  Windtree Therapeutics Inc. reported its third quarter 2024 results, ending September 30, 2024. The company had minimal revenue and significant operating expense
• Windtree Therapeutics Q2 2024: Net Loss of $33.1M — Aug 19, 2024 Risk: high
  Windtree Therapeutics Inc. filed its 10-Q for the period ending June 30, 2024. The company reported total assets of $5.5 million and total liabilities of $4.99
• Windtree Therapeutics Files 10-Q for Q1 2024 — May 15, 2024 Risk: high
  WINDTREE THERAPEUTICS INC /DE/ (WINTW) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Revenue for the three months ended March 31, 2024, was $0.0

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX